SIGLEC7 and neoplasm: Releasing the brake on effector cells such as NK cells and cytotoxic T cells by blocking Siglec‐7 could potentially increase tumor control, as it has previously been shown that Siglec‐7 can inhibit NK cell cytotoxicity and effector T cell functions.29, 36, 37, 39